HBM BIOVENTURES CAYMAN LTD 13D/13G Filings for Benitec Biopharma Inc. (BNTC)

HBM BIOVENTURES CAYMAN LTD 13D and 13G filings for Benitec Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-13
4:15 pm
Unchanged		 2024-12-31 13G Benitec Biopharma Inc.
BNTC		 HBM BIOVENTURES CAYMAN LTD 1,041,669
4.500%		 0
(Unchanged)		 Filing
2024-11-13
4:18 pm
Purchase		 2024-09-30 13G Benitec Biopharma Inc.
BNTC		 HBM BIOVENTURES CAYMAN LTD 1,041,669
9.700%		 191,776increase
(+22.56%)		 Filing
2024-04-29
4:05 pm
Purchase		 2024-04-17 13G Benitec Biopharma Inc.
BNTC		 HBM BIOVENTURES CAYMAN LTD 849,893
9.990%		 849,893increase
(New Position)		 Filing